BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng W, Xu Q, Zhang Y, E X, Gao W, Zhang M, Zhai W, Rajkumar RS, Liu Z. Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways. Virol J 2020;17:192. [PMID: 33298111 DOI: 10.1186/s12985-020-01463-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim S, Nowakowska A, Kim YB, Shin HY. Integrated CRISPR-Cas9 System-Mediated Knockout of IFN-γ and IFN-γ Receptor 1 in the Vero Cell Line Promotes Viral Susceptibility. Int J Mol Sci 2022;23:8217. [PMID: 35897807 DOI: 10.3390/ijms23158217] [Reference Citation Analysis]
2 Girkin JLN, Maltby S, Bartlett NW. Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell. Eur Respir Rev 2022;31:210274. [PMID: 35508333 DOI: 10.1183/16000617.0274-2021] [Reference Citation Analysis]
3 Medhasi S, Chindamporn A, Worasilchai N. A Review: Antimicrobial Therapy for Human Pythiosis. Antibiotics 2022;11:450. [DOI: 10.3390/antibiotics11040450] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kumar J, Dandapat S, Panickan S, Kumar A, Singh M, Bindu S, Dhama K. Expression profiles of toll like receptors, MHC and cytokine genes along with viral load in organs of ducklings infected with an Indian isolate of duck enteritis virus. Microb Pathog 2022;165:105502. [PMID: 35339656 DOI: 10.1016/j.micpath.2022.105502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shikama Y, Kurosawa M, Furukawa M, Kudo Y, Ishimaru N, Matsushita K. The Priming Potential of Interferon Lambda-1 for Antiviral Defense in the Oral Mucosa. Inflammation 2022. [PMID: 35044570 DOI: 10.1007/s10753-022-01624-1] [Reference Citation Analysis]
6 Ma F, Lf D, Ei T, Pa G. Herpes simplex virus interference with immunity: Focus on dendritic cells. Virulence 2021;12:2583-607. [PMID: 34895058 DOI: 10.1080/21505594.2021.1980990] [Reference Citation Analysis]
7 Stępień E, Strycharz-Dudziak M, Malm M, Drop B, Polz-Dacewicz M. Serum and Tissue Level of TLR9 in EBV-Associated Oropharyngeal Cancer. Cancers (Basel) 2021;13:3981. [PMID: 34439137 DOI: 10.3390/cancers13163981] [Reference Citation Analysis]
8 Marozzi M, Parnigoni A, Negri A, Viola M, Vigetti D, Passi A, Karousou E, Rizzi F. Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment. Int J Mol Sci 2021;22:8102. [PMID: 34360868 DOI: 10.3390/ijms22158102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
9 Poole EL, Nevels MM. Editorial: Cytomegalovirus Pathogenesis and Host Interactions. Front Cell Infect Microbiol 2021;11:711551. [PMID: 34307201 DOI: 10.3389/fcimb.2021.711551] [Reference Citation Analysis]
10 Šudomová M, Hassan STS. Nutraceutical Curcumin with Promising Protection against Herpesvirus Infections and Their Associated Inflammation: Mechanisms and Pathways. Microorganisms 2021;9:292. [PMID: 33572685 DOI: 10.3390/microorganisms9020292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Zheng W, Xu Q, Zhang Y, E X, Gao W, Zhang M, Zhai W, Rajkumar RS, Liu Z. Correction to: Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways. Virol J 2020;17:199. [PMID: 33384018 DOI: 10.1186/s12985-020-01481-0] [Reference Citation Analysis]